The Gross Law Firm
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of PRVB, HMPT and RKT
NEW YORK, NY / ACCESSWIRE / July 15, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.
Provention Bio, Inc. (NASDAQ:PRVB)
Investors Affected : November 2, 2020 - April 8, 2021
A class action has commenced on behalf of certain shareholders in Provention Bio, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) the teplizumab Biologics License Application ("BLA") was deficient in its submitted form and would require additional data to secure U.S. Food and Drug Administration approval; (ii) accordingly, the teplizumab BLA lacked the evidentiary support the Company had led investors to believe it possessed; (iii) the Company had thus overstated the teplizumab BLA's approval prospects and hence the commercialization timeline for teplizumab; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.
Shareholders may find more information at https://securitiesclasslaw.com/securities/provention-bio-inc-loss-submission-form/?id=17675&from=1
Home Point Capital Inc. (NASDAQ:HMPT)
This lawsuit is on behalf of all persons and entities other than Defendants that purchased or otherwise acquired Home Point common stock pursuant and/or traceable to the Company's January 29, 2021 initial public offering.
A class action has commenced on behalf of certain shareholders in Home Point Capital Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) Home Point's aggressive expansion of its broker partners would dramatically increase the Company's expenses; (ii) the mortgage industry was anticipating industry-wide decreased gain-on-sale margins as a result of rising interest rates in 2021 and Home Point would be subject to the same competitive pressures; (iii) accordingly, the Company had overstated its business and financial prospects; and (iv) as a result, the Offering Documents were materially false and/or misleading and failed to state information required to be stated therein.
Shareholders may find more information at https://securitiesclasslaw.com/securities/home-point-capital-inc-loss-submission-form/?id=17675&from=1
Rocket Companies, Inc. (NYSE:RKT)
Investors Affected : February 25, 2021 - May 5, 2021
A class action has commenced on behalf of certain shareholders in Rocket Companies, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (a) Rocket's gain on sale margins were contracting at the highest rate in two years as a result of increased competition among mortgage lenders, an unfavorable shift toward the lower margin Partner Network operating segment and compression in the price spread between the primary and secondary mortgage markets; (b) Rocket was engaged in a price war and battle for market share with its primary competitors in the wholesale market, which was further compressing margins in Rocket's Partner Network operating segment; (c) the adverse trends identified above were accelerating and, as a result, Rocket's gain on sale margins were on track to plummet at least 140 basis points in the first six months of 2021; (d) as a result of the above, the favorable market conditions that had preceded the Class Period and allowed Rocket to achieve historically high gain on sale margins had vanished as the Company's gain on sale margins had returned to levels not seen since the first quarter of 2019; (e) rather than remaining elevated due to surging demand, Rocket's Company-wide gain-on-sale margins had fallen materially below recent historical averages; and (f) as a result of the foregoing, defendants' positive statements about the Company's business operations and prospects were materially misleading and/or lacked a reasonable basis.
Shareholders may find more information at https://securitiesclasslaw.com/securities/rocket-companies-inc-loss-submission-form/?id=17675&from=1To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Phone: (212) 537-9430
Fax: (833) 862-7770
SOURCE: The Gross Law Firm
View source version on accesswire.com:
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
Subscribe to releases from ACCESSWIRE
Subscribe to all the latest releases from ACCESSWIRE by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESSWIRE
iZafe Group3.12.2021 15:02:05 CET | Press release
The First Italian Version of Dosell was sent Today to Sempli Farma in Italy
Gungnir Resources Inc.2.12.2021 18:40:50 CET | Press release
Gungnir Drills 6.52% Nickel over 0.8 Metres within 4.5 Metres of 2.04% Nickel plus 12 Metres of 1.13% Nickel at Lappvattnet
Proactive Investors2.12.2021 15:16:48 CET | Press release
Proactive Interviews NexTech AR Solutions Chief Executive Evan Gappelberg Who Discusses Just Why His New SaaS Model Is a 'Big Deal'
iZafe Group2.12.2021 13:32:03 CET | Press release
Zafe Care Systems Places Order for the Pharmaceutical Robot Dosell
Spago Nanomedical2.12.2021 11:01:32 CET | Press release
Second Dose Group Fully Recruited in Spago Nanomedical's Phase 1 Study with SpagoPix
Linkfire1.12.2021 23:27:57 CET | Press release
Linkfire ("LINKFI") Renews Global Agreement with Warner Music
Finovate1.12.2021 15:04:06 CET | Press release
Finovate Underlines Commitment to Diversity with 50% Female Speaker Lineup
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom